15 Comments
Eduardo Ferreira De Araujo
Eduardo Ferreira De Araujo
Eduardo Ferreira De Araujo
Eduardo Ferreira De Araujo

In response to What is your path to financial sustainability?

For how long do you expect to be reliant on grant and funding, other than self-generated revenue?

Brandon Dottin-Haley

We expect to continue to apply for grant funding to support additional research and deployment in low and middle-income communities. Revenue from sales will also be used to support growth and production. We have secured the funding to grow our solution, but would benefit tremendously from additional support to increase the rate at which we scale.

Eduardo Ferreira De Araujo

In response to What is your business model?

What would be the price of (i) device and (ii) subscription service to end user? How does this compare to other solutions and also to purchasing power in targeted areas?

Brandon Dottin-Haley

The FeelixPro device will retail for $399 USD, and we offer a subscription to clinicians for $19.99/mon. This is comparable to the ThinkLabs One digital stethoscope, priced at $499, which features no adaptive noise suppression or on-board storage. The Littman 3200, priced at $419, is perhaps one of the most common digital stethoscopes, but similarly lacks in sound quality. We are currently exploring pricing models for lower resource communities who would benefit from the deployment of the Feelix device, which is priced at $299 USD. The cost of a Feelix screening is orders of magnitude cheaper when compared to wet lab tests that require significant time and resources, but we are searching for ways to make the devices even more affordable for low and middle income communities.

 
    Back
to Top